High time to tackle drug-resistant fungal infections

Candida auris, a yeast resistant to antifungal drugs, claims over 3.8 million lives annually from fungal infections, up by nearly 50% in the past decade. Its spread demands urgent attention for diagnosis and treatment, especially in low-income regions where delayed diagnoses lead to inappropriate treatments. Agricultural use of similar fungicides worsens resistance, highlighting the need for global cooperation like India's antibiotic ban and the US EPA's guidelines. Investments in safer fungal treatments remain crucial to combat this growing threat.